The Importance of the Insulin-like Growth Factor Signaling Pathway in Lung Cancer and the Potential of its Components as Therapeutic Targets
作者： Sarah Elizabeth Franks
DOI:
关键词: Signal transduction 、 Cancer research 、 Insulin-like growth factor 、 Lung cancer 、 Growth factor receptor inhibitor 、 Growth factor receptor 、 Biology
摘要:
uoguelph.ca参考文章(277)
Gumus M, Ozdemir Barisik N, Aksu A, Karabulut Gul S, Bilici A, Kocak M, Fatih Oruc A, Mayadagli A, Ozkan A, Prognostic significance of protein kinase B/Akt pathway in patients with non-small cell lung cancer. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. ,vol. 19, pp. 157- ,(2014)
Katsuaki Sato, Toshiki Takemoto, Takuya Iwasaki, Tetsuya Mitsudomi, Kenichi Suda, Hiroshi Mizuuchi, The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor International Journal of Cancer. ,vol. 135, pp. 1002- 1006 ,(2014) , 10.1002/IJC.28737
E. Rinderknecht, R.E. Humbel, The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. Journal of Biological Chemistry. ,vol. 253, pp. 2769- 2776 ,(1978) , 10.1016/S0021-9258(17)40889-1
J Massagué, M P Czech, The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. Journal of Biological Chemistry. ,vol. 257, pp. 5038- 5045 ,(1982) , 10.1016/S0021-9258(18)34631-3
R C Baxter, J L Martin, V A Beniac, High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. Journal of Biological Chemistry. ,vol. 264, pp. 11843- 11848 ,(1989) , 10.1016/S0021-9258(18)80143-0
Jasminka Pavelić, Ljubomir Pavelić, Jerolim Karadža, Šimun Križanac, Josip Unešić, Šime Spaventi, Krešimir Pavelić, Insulin-like growth factor family and combined antisense approach in therapy of lung carcinoma. Molecular Medicine. ,vol. 8, pp. 149- 157 ,(2002) , 10.1007/BF03402007
Victor Jeannot, Benoît Busser, Elisabeth Brambilla, Marie Wislez, Blaise Robin, Jacques Cadranel, Jean-Luc Coll, Amandine Hurbin, The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase‐dependent mechanism International Journal of Cancer. ,vol. 134, pp. 2560- 2571 ,(2014) , 10.1002/IJC.28594
Sean Arkins, Sean Arkins, Robert Dantzer, Christian Minshall, Keith W. Kelley, Gregory G. Freund, James Straza, James Conners, IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. Journal of Immunology. ,vol. 159, pp. 1225- 1232 ,(1997)
H. Imai, N. Sunaga, Y. Shimizu, S. Kakegawa, K. Shimizu, T. Sano, T. Ishizuka, T. Oyama, R. Saito, J.D. Minna, M. Mori, Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer. International Journal of Immunopathology and Pharmacology. ,vol. 23, pp. 153- 164 ,(2010) , 10.1177/039463201002300114
Patrick Chames, Marc Van Regenmortel, Etienne Weiss, Daniel Baty, Therapeutic antibodies: successes, limitations and hopes for the future. British Journal of Pharmacology. ,vol. 157, pp. 220- 233 ,(2009) , 10.1111/J.1476-5381.2009.00190.X